DIALYSIS ANAEMIA
نویسندگان
چکیده
منابع مشابه
Testosterone therapy for anaemia in maintenance dialysis.
Intramuscular testosterone 250-500 mg weekly given to 25 patients on long-term haemodialysis produced a significant rise in haemoglobin level in all patients. The response was reversible when the drug was stopped. Treatment was effective in bilaterally nephrectomized patients and those with intact kidney tissue. The use of intramuscular testosterone is recommended for all adult patients on long...
متن کاملPRE-dialysis survey on anaemia management.
BACKGROUND The PRE-dialysis survey on anaemia management (PRESAM) was designed to assess the care given to pre-dialysis patients in the 12 months before haemodialysis or peritoneal dialysis, with emphasis on anaemia management. METHODS For this epidemiological study, a retrospective chart review was conducted for patients who started haemodialysis or peritoneal dialysis between 1 August, 1999...
متن کاملAnaemia management prior to dialysis: cardiovascular and cost-benefit observations.
Anaemia correction with recombinant human erythropoietin (rh-EPO, epoetin) in end-stage renal disease (ESRD) patients has been associated with improved survival and quality of life, as well as lower overall treatment costs. Few studies, however, have evaluated the benefits of epoetin treatment given to chronic kidney disease (CKD) patients during the pre-dialysis period. A retrospective study o...
متن کاملAn opportunity to intervene: erythropoietin for the treatment of anaemia in pre-dialysis patients.
17. Feng L, Xia Y, Tang W, Hwang D, Wilson C. Expression of cyclooxygenase (COX)-l, COX-2, and cytosolic phopspholipase A2 (cPLA2) in anti-GBM antibody (Ab) glomerulonephritis (GN) (abstract). J Am Soc Nephrol1993; 4: 452 18. Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol...
متن کاملEvaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.
BACKGROUND Inadequate anaemia correction (haemoglobin (Hb) <11 g/dl without receiving an erythropoiesis-stimulating agent (ESA) is common in pre-dialysis patients, but little is known about its determinants. We used data from the French end-stage renal disease (ESRD) registry to investigate these determinants and the patients' anaemia status 1 year after starting dialysis. METHODS Pre-dialysi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2014
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/gfu176